Working capital / assets moved 498 bp higher
Working capital / assets changed +498 basis points from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
63.49%→68.46%4 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →SOTK financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating margin moved 87 bp lower
Operating margin changed -87 basis points from the comparable as-filed period.
8.16%→7.29%3 prior comparisons
Stock-based compensation increased 23.9%
Stock-based compensation changed +23.9% from the comparable as-filed period.
$71,000→$88,0003 prior comparisons
Revenue increased 1.3%
Revenue changed +1.3% from the comparable as-filed period.
$5.2M→$5.2M3 prior comparisons
Research & development increased 8.3%
Research & development changed +8.3% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$627,278→$679,1603 prior comparisons
Operating income decreased 9.4%
Operating income changed -9.4% from the comparable as-filed period.
$421,154→$381,5313 prior comparisons
Inventory decreased 7.7%
Inventory changed -7.7% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$4.2M→$3.8M4 prior comparisons
R&D / revenue moved 83 bp higher
R&D / revenue changed +83 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
12.15%→12.98%3 prior comparisons
SBC / revenue moved 31 bp higher
SBC / revenue changed +31 basis points from the comparable as-filed period.
1.38%→1.68%3 prior comparisons
Gross profit increased 6.8%
Gross profit changed +6.8% from the comparable as-filed period.
$2.6M→$2.8M3 prior comparisons
Cost of revenue decreased 4.2%
Cost of revenue changed -4.2% from the comparable as-filed period.
$2.6M→$2.5M3 prior comparisons
Current ratio increased 1.8%
Current ratio changed +1.8% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
4.34→4.424 prior comparisons
Free-cash-flow proxy changed across a sign change
Free-cash-flow proxy changed +290.8% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
-$974,542→$1.9M3 prior comparisons
Operating cash flow changed across a sign change
Operating cash flow changed +310.4% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
-$922,293→$1.9M3 prior comparisons
Revenue increased 10.3%
Revenue changed +10.3% from the comparable as-filed period.
$5.1M→$5.7M3 prior comparisons
Current assets increased 19.4%
Current assets changed +19.4% from the comparable as-filed period.
$19.0M→$22.6M3 prior comparisons
Working capital / assets moved 799 bp higher
Working capital / assets changed +799 basis points from the comparable as-filed period.
59.52%→67.51%3 prior comparisons
Operating cash-flow margin moved 5225 bp higher
Operating cash-flow margin changed +5225 basis points from the comparable as-filed period.
-17.97%→34.28%3 prior comparisons
Free-cash-flow margin moved 5183 bp higher
Free-cash-flow margin changed +5183 basis points from the comparable as-filed period.
-18.99%→32.84%3 prior comparisons
Inventory decreased 14.4%
Inventory changed -14.4% from the comparable as-filed period.
$4.7M→$4.1M3 prior comparisons
Gross profit increased 20.6%
Gross profit changed +20.6% from the comparable as-filed period.
$2.7M→$3.2M3 prior comparisons
Capex / revenue moved 42 bp higher
Capex / revenue changed +42 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
1.02%→1.44%3 prior comparisons
Total assets increased 10.4%
Total assets changed +10.4% from the comparable as-filed period.
$23.4M→$25.9M3 prior comparisons
R&D / revenue moved 213 bp lower
R&D / revenue changed -213 basis points from the comparable as-filed period.
13.02%→10.90%3 prior comparisons
Current ratio increased 15.9%
Current ratio changed +15.9% from the comparable as-filed period.
3.77→4.373 prior comparisons
Stock-based compensation increased 14.2%
Stock-based compensation changed +14.2% from the comparable as-filed period.
$75,163→$85,8253 prior comparisons
Research & development decreased 7.7%
Research & development changed -7.7% from the comparable as-filed period.
$668,470→$616,9823 prior comparisons
Shares outstanding decreased 0.1%
Shares outstanding changed -0.1% from the comparable as-filed period. The change ranks at the 25th percentile of 8 prior comparable changes.
15,727,702→15,716,7238 prior comparisons
SBC / revenue moved 5 bp higher
SBC / revenue changed +5 basis points from the comparable as-filed period.
1.46%→1.52%3 prior comparisons
Current liabilities increased 3.0%
Current liabilities changed +3.0% from the comparable as-filed period.
$5.0M→$5.2M3 prior comparisons
Cost of revenue decreased 0.9%
Cost of revenue changed -0.9% from the comparable as-filed period.
$2.5M→$2.4M3 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.